Intracranial stenting as monotherapy in subarachnoid hemorrhage and sickle cell disease

Journal of NeuroInterventional Surgery

Volumn 5, Issue 2, 2013, Pages

  Ediriwickrema, Asiri ^a   Williamson, Theresa ^a   Hebert, Ryan ^a   Matouk, Charles ^a   Johnson, Michele H ^a   Bulsara, Ketan R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN S;

ADULT; ANASTOMOSIS; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN ARTERY ANEURYSM; CASE REPORT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; EXCHANGE BLOOD TRANSFUSION; FOLLOW UP; HEADACHE; HUMAN; INTRACRANIAL STENT; MALE; OUTCOME ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; SICKLE CELL ANEMIA; STENT; SUBARACHNOID HEMORRHAGE; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE FUNCTION;

ADULT; ANEMIA, SICKLE CELL; HUMANS; INTRACRANIAL ANEURYSM; MALE; STENTS; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 84874611455     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/neurintsurg-2011-010224     Document Type: Article

References (30)

1. Moran CJ, Siegel MJ, Debaun MR. Sickle cell disease: imaging of cerebrovascular complications. Radiology 1998;206: 311-21. (Pubitemid 28112942)
2. Liaquat I, Murphy M, Bassi S, et al. Paediatric and adult vascular intracranial complications of sickle-cell disease. Acta Neurochir (Wien) 2010;152: 1175-9.
3. Vicari P, Choairy AC, Siufi GC, et al. Embolization of intracranial aneurysms and sickle cell disease. Am J Hematol 2004;76: 83-4. (Pubitemid 38579546)
4. Sydenstricked V, Mulherin W, Houseal R. Sickle cell anemia: report of two cases in children, with necropsy in one case. Am J Dis Child 1923;26: 132-54.
5. Bridgers WH. Cerebral vascular disease accompanying sickle cell anemia. Am J Pathol 1939;15: 353-61.
6. Hughes JG, Diggs LW, Gillespie CE. The involvement of the nervous system in sickle-cell anemia. J Pediatr 1940;17: 166-84.
7. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998;91: 288-94. (Pubitemid 28018756)
8. Inci S, Erbengi A, Berker M. Pulmonary embolism in neurosurgical patients. Surg Neurol 1995;43: 123-8.
9. Heesen M, Winking M, Kemkes-Matthes B, et al. What the neurosurgeon needs to know about the coagulation system. Surg Neurol 1997;47: 32-4. (Pubitemid 27009154)
10. Ataga KI, Key NS. Hypercoagulability in sickle cell disease: new approaches to an old problem. Hematology Am Soc Hematol Educ Program 2007;91-6.
11. Adedeji MO, Cespedes J, Allen K, et al. Pulmonary thrombotic arteriopathy in patients with sickle cell disease. Arch Pathol Lab Med 2001;125: 1436-41. (Pubitemid 33070181)
12. Natarajan K, Townes T, Kutlar A. Disorders of hemoglobin structure: sickle cell anemia and related abnormalities. In: Lichtman MA, ed. Williams hematology. New York: McGraw-Hill, 2011: 871-914.
13. Rothman SM, Fulling KH, Nelson JS. Sickle cell anemia and central nervous system infarction: a neuropathological study. Ann Neurol 1986;20: 684-90. (Pubitemid 17207642)
14. Switzer JA, Hess DC, Nichols FT, et al. Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol 2006;5: 501-12.
15. Biller J, Love BB, Schneck MJ. Vascular diseases of the nervous system: ischemic cerebrovascular disease. In: Bradley WG, Daroff RB, Marsden D, et al, eds. Neurology in clinical practice. Philadelphia, PA: Butterworth Heinemann Elsevier, 2008.
16. Reiter CD, Wang X, Tanus-Santos JE, et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 2002;8: 1383-9. (Pubitemid 36019423)
17. Stuart MJ, Nagel RL. Sickle-cell disease. Lancet 2004;364: 1343-60. (Pubitemid 39335827)
18. Kaul DK, Hebbel RP. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest 2000;106: 411-20. (Pubitemid 30655641)
19. Lee SP, Ataga KI, Orringer EP, et al. Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation. Arterioscler Thromb Vasc Biol 2006;26: 1626-31. (Pubitemid 44288993)
20. Firth PG, Pterfreund RA. Management of multiple intracranial aneurysms: neuroanesthetic considerations of sickle cell disease. J Neurosurg Anesthesiol 2000;12: 366-71.
21. Oyesiku NM, Barrow DL, Eckman JR, et al. Intracranial aneurysms in sickle-cell anemia: clinical features and pathogenesis. J Neurosurg 1991;75: 356-63.
22. Diggs LW, Brookoff D. Multiple cerebral aneurysms in patients with sickle cell disease. South Med J 1993;86: 377-9. (Pubitemid 23117231)
23. Brandão RA, de Carvalho GT, Reis BL, et al. Intracranial aneurysms in sickle cell patients: report of 2 cases and review of the literature. Surg Neurol 2009;72: 296-9.
24. Hanel RA, Spetzler RF. Surgical treatment of complex intracranial aneurysms. Neurosurgery 2008;62(6 Suppl 3): 1289-97.
25. Andaluz N, Zuccarello M. Treatment strategies for complex intracranial aneurysms: review of a 12-year experience at the University of Cincinnati. Skull Base 2011;21: 233-42.
26. McQuaker IG, Jaspan T, McConachie NS, et al. Coil embolization of cerebral aneurysms in patients with sickling disorders. Br J Haematol 1999;106: 388-90. (Pubitemid 29450662)
27. Evans J, Saba Z, Rosenfeld H, et al. Aortic laceration secondary to palmaz stent placement for treatment of superior vena cava syndrome. Catheter Cardiovasc Interv 2000;49: 160-2. (Pubitemid 30075539)
28. Alhadad A, Kölbel T, Herbst A, et al. Iliocaval vein stenting: long term survey of postthrombotic symptoms and working capacity. J Thromb Thrombolysis 2011;31: 211-16.
29. Matsui NM, Varki A, Embury SH. Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin. Blood 2002;100: 3790-6. (Pubitemid 35303953)
30. Lee SP, Ataga KI, Zayed M, et al. Phase I study of eptifibatide in patients with sickle cell anaemia. Br J Haematol 2007;139: 612-20. (Pubitemid 350043807)